Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone
- Conditions
- PostoperativeHepato-Biliary NeoplasmNutritional Support
- Interventions
- Dietary Supplement: parenteral nutrition supplementsDietary Supplement: enteral nutrition supplementsDietary Supplement: mixed nutrition supplements
- Registration Number
- NCT06397430
- Lead Sponsor
- Karaganda Medical University
- Brief Summary
A comprehensive comparative analysis of the effectiveness of isolated enteral, isolated parenteral and mixed type of nutritional support in the early postoperative period in patients after operations performed on the malignant neoplasms of hepatico-pancreatico-duodenal zone.
- Detailed Description
A prospective, longitudinal, parallel study and retrospective analysis of the results of treatment of 91 patients with malignant tumors of the hepatico-pancreato-duodenal zone who underwent the following operations:
1. resection of various segments of the liver;
2. hemihepatectomy;
3. transhepatic drainage of the right and left hepatic duct;
4. bypass gastroenteroanastomosis or cholecystenteroanastomosis with interintestinal enteroenteroanastomosis according to Brown;
5. gastro-pancreato-duodenal resection;
6. corpore-caudal resection of the pancreas with splenectomy.
The first group (n=31) included patients who received enteral nutrition (EN) after surgery. The second group (n=30) included patients who received parenteral nutrition (PN) and the third group (n=30) who received mixed nutrition (MN), as a variation of the partial parenteral nutrition technique, in the early postoperative period.
Some nutritional status indicators available for determination at the Oncology Clinic were assessed - body mass index (weight measurements were carried out before surgery, on the 5th, 10th and 15th days), basal metabolic rate (calculated using the Harris-Benedict equation, based on anthropometric data of the patient (gender, age, weight and height).), laboratory parameters: blood hemoglobin, lymphocytes, total protein, serum albumin, serum transferrin, total bilirubin and direct, alanine aminotransferase (ALT), aspartate aminotransferase (AST), which are related to the traditional method for assessing nutritional status
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 91
female and male patients in age of 20-75 with malignant tumors of the hepato-pancreato-duodenal zone who have undergone any of the following operations:
- resection of various segments of the liver;
- hemihepatectomy;
- transhepatic drainage of the right and left hepatic duct;
- bypass gastroenteroanastomosis or cholecystoenteroanastomosis with interintestinal enteroenteroanastomosis according to Brown;
- gastro-pancreatoduodenal resection;
- corporecaudal resection of the pancreas with splenectomy.
- patients in age of up to 20 and older than 75
- pregnant and breastfeeding women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm 2 - parenteral nutrition parenteral nutrition supplements patients receiving parenteral nutrition (PN) Arm 1 - enteral nutrition enteral nutrition supplements patients receiving enteral nutrition (EN) after surgery Arm 3 - mixed nutrition mixed nutrition supplements patients receiving mixed nutrition (MF)
- Primary Outcome Measures
Name Time Method Serum albumin in g/L Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: serum albumin in g/L
ALT in IU/L Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: ALT in IU/L
AST in IU/L Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: AST in IU/L
Total protein level in Blood Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: total protein in g/L
Number of Participants with changes of BMI in kg/m^2 Day 0, Day 5, Day 10, Day15 Variables of Body mass index measured by Canadian Guidelines for Body Weight Classification in Adults
Serum transferrin in g/L Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: serum transferrin in g/L
Total bilirubin in mmol/L Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: total bilirubin in mmol/L
Direct bilirubin in mmol/L Day 0, Day 5, Day 10, Day15 Blood biochemical analysis: direct bilirubin in mmol/L
Basal Metabolic rate Day 0, Day 5, Day 10, Day15 basal metabolic rate according to the Harris-Benedict equation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Karaganda Medical University
🇰🇿Karaganda, Kazakhstan